International Journal of Hematology

Aims & Scope

The International Journal of Hematology, the official journal of the Japanese Society of Hematology, has a long history of publishing leading research in hematology.

The journal comprises articles that contribute to progress in research not only in basic hematology but also in clinical hematology, aiming to cover all aspects of this field, namely, erythrocytes, leukocytes and hematopoiesis, hemostasis, thrombosis and vascular biology, hematological malignancies, transplantation, and cell therapy.

The expanded [Progress in Hematology] section integrates such relevant fields as the cell biology of stem cells and cancer cells, and clinical research in inflammation, cancer, and thrombosis.

Reports on results of clinical trials are also included, thus contributing to the aim of fostering communication among researchers in the growing field of modern hematology.

The journal provides the best of up-to-date information on modern hematology, presenting readers with high-impact, original work focusing on pivotal issues.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	1.8
2024	1.70

Journal Rank

Year	Value
2024	8830

SJR (SCImago Journal Rank)

Year	Value
2024	0.651

Journal Citation Indicator

Year	Value
2024	1171

Quartile

Year	Value
2024	Q2

h-index

Year	Value
2024	89

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Body iron metabolism and pathophysiology of iron overload

  Citation: 482

  Authors: Yutaka, Katsuya, Takaaki, Yoshihiro, Junji

• Nationwide Survey of Hemophagocytic Lymphohistiocytosis in Japan

  Citation: 369

  Authors: Eiichi, Shouichi, Shinsaku, Masaki, Hiroyuki, Ikuo, Ken, Hisanori, Kenzo, Koichi, Shigeo, Naoko, Kazuo, Keisei

• COVID-19-associated coagulopathy and disseminated intravascular coagulation

  Citation: 334

  Authors: Hidesaku, Haruhiko

• Introduction of Transplant Registry Unified Management Program 2 (TRUMP2): scripts for TRUMP data analyses, part I (variables other than HLA-related data)

  Citation: 306

  Authors: Yoshiko

• Iron and infection

  Citation: 232

  Authors: Tomas

• The biology of thrombopoietin and thrombopoietin receptor agonists

  Citation: 218

  Authors: David J.

• Citation: 195

  Authors:

• Pathophysiology of thrombotic thrombocytopenic purpura

  Citation: 193

  Authors: Han-Mou

• Iron Toxicity and Chelation Therapy

  Citation: 182

  Authors: Robert S., Katherine L., Bruce R.

• Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version

  Citation: 171

  Authors: Yasufumi, Hiroshi, Kazue, Masaru, Norifumi, Yasuhito, Nozomu, Makoto, Jun, Kenji, Hiroshi, Yoko, Hidekazu, Katsuhiro, Tsutomu, Shinichirou, Akihito, Nobuyasu, Soichiro, Yasunori, Natsue, Shino, Haruka, Tomoyuki, Takafumi, Yoshimasa, Toshihiro, Shigeo, Tomohiro, Sadao

---